Secondary Logo

Journal Logo

November 28th, 2015 - Volume 29 - Issue 18
pp: 2371-2537


Towards depersonalized abacavir therapy: chemical modification eliminates HLA-B*57 : 01-restricted CD8+ T-cell activation

Naisbitt, Dean J.; Yang, Emma L.; Alhaidari, Mohammad; More

AIDS. 29(18):2385-2395, November 28th, 2015.

In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3ζ expression through ELF-1 inhibition

Tumino, Nicola; Turchi, Federica; Meschi, Silvia; More

AIDS. 29(18):2397-2407, November 28th, 2015.


CONCISE COMMUNICATIONS



Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand

Lallemant, Marc; Le Coeur, Sophie; Sirirungsi, Wasna; More

AIDS. 29(18):2497-2507, November 28th, 2015.

The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV

Kohler, Philipp; Schmidt, Axel J.; Cavassini, Matthias; More

AIDS. 29(18):2509-2515, November 28th, 2015.

CONCISE COMMUNICATION




Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo

Konou, Abla A.; Dagnra, Anoumou Y.; Vidal, Nicole; More

AIDS. 29(18):2527-2530, November 28th, 2015.


Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1

Pinnetti, Carmela; Tintoni, Mauro; Ammassari, Adriana; More

AIDS. 29(18):2534-2537, November 28th, 2015.

Show: